Junqi Luo

502 total citations
9 papers, 360 citations indexed

About

Junqi Luo is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Junqi Luo has authored 9 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Junqi Luo's work include Circular RNAs in diseases (3 papers), Cancer-related molecular mechanisms research (3 papers) and Ferroptosis and cancer prognosis (3 papers). Junqi Luo is often cited by papers focused on Circular RNAs in diseases (3 papers), Cancer-related molecular mechanisms research (3 papers) and Ferroptosis and cancer prognosis (3 papers). Junqi Luo collaborates with scholars based in China and United States. Junqi Luo's co-authors include Taowei Yang, Xumin Zhou, Wenbin Chen, Libin Zou, Kaihui Wu, Shengren Cen, Fangpeng Shu, Xiangming Mao, Daojun Lv and Xiangming Mao and has published in prestigious journals such as Free Radical Biology and Medicine, Cell Death and Disease and Pharmacological Research.

In The Last Decade

Junqi Luo

9 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junqi Luo China	8	255	218	125	45	32	9	360
Jinchun Xing China	10	220 0.9×	145 0.7×	116 0.9×	39 0.9×	21 0.7×	14	305
Yunyun Li China	9	210 0.8×	194 0.9×	84 0.7×	34 0.8×	23 0.7×	17	305
Guannan Shu China	12	320 1.3×	249 1.1×	93 0.7×	38 0.8×	23 0.7×	17	407
Zhou Yang China	7	214 0.8×	174 0.8×	113 0.9×	47 1.0×	20 0.6×	12	344
Yihui Pan China	11	389 1.5×	308 1.4×	109 0.9×	44 1.0×	18 0.6×	16	483
Jiantao Mo China	6	192 0.8×	156 0.7×	94 0.8×	40 0.9×	26 0.8×	14	283
Pengshan Zhang China	7	251 1.0×	171 0.8×	114 0.9×	64 1.4×	45 1.4×	17	423
Junmi Lu China	13	368 1.4×	268 1.2×	82 0.7×	71 1.6×	32 1.0×	23	487
Christina M. Bebber Germany	4	268 1.1×	230 1.1×	294 2.4×	54 1.2×	22 0.7×	6	393

Countries citing papers authored by Junqi Luo

Since Specialization

Citations

This map shows the geographic impact of Junqi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junqi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junqi Luo more than expected).

Fields of papers citing papers by Junqi Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junqi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junqi Luo. The network helps show where Junqi Luo may publish in the future.

Co-authorship network of co-authors of Junqi Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Junqi Luo. A scholar is included among the top collaborators of Junqi Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junqi Luo. Junqi Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Luo, Junqi, Bingxin Lu, Chengzhi Luo, et al.. (2025). Adipose stem cells ameliorate erectile dysfunction in diabetes mellitus rats by attenuating ferroptosis through NRP1 with SLC7A11 interaction. Free Radical Biology and Medicine. 232. 40–55. 2 indexed citations

Luo, Junqi, Taowei Yang, Jun Wu, et al.. (2023). Exosomal PGAM1 promotes prostate cancer angiogenesis and metastasis by interacting with ACTG1. Cell Death and Disease. 14(8). 40 indexed citations

Zou, Libin, Wenbin Chen, Xumin Zhou, et al.. (2022). N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability. Cell Death Discovery. 8(1). 184–184. 33 indexed citations

Zhou, Xumin, Libin Zou, Hangyu Liao, et al.. (2021). Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer. Acta Pharmaceutica Sinica B. 12(2). 692–707. 78 indexed citations

Tan, Xiao, Wenbin Chen, Daojun Lv, et al.. (2021). LncRNA SNHG1 and RNA binding protein hnRNPL form a complex and coregulate CDH1 to boost the growth and metastasis of prostate cancer. Cell Death and Disease. 12(2). 138–138. 40 indexed citations

Chen, Wenbin, Shengren Cen, Xumin Zhou, et al.. (2021). Circular RNA CircNOLC1, Upregulated by NF-KappaB, Promotes the Progression of Prostate Cancer via miR-647/PAQR4 Axis. Frontiers in Cell and Developmental Biology. 8. 624764–624764. 41 indexed citations

Shu, Fangpeng, Taowei Yang, Xuefeng Zhang, et al.. (2021). Hyaluronic acid modified covalent organic polymers for efficient targeted and oxygen-evolved phototherapy. Journal of Nanobiotechnology. 19(1). 4–4. 20 indexed citations

Lü, Jianming, Chuanfan Zhong, Junqi Luo, et al.. (2021). HnRNP-L-regulated circCSPP1/miR-520h/EGR1 axis modulates autophagy and promotes progression in prostate cancer. Molecular Therapy — Nucleic Acids. 26. 927–944. 33 indexed citations

Zhou, Xumin, Libin Zou, Wenbin Chen, et al.. (2020). Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer. Pharmacological Research. 164. 105305–105305. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact